Richmond Pharmacology is a frequent contributor and recognised thought leader for various scientific meetings worldwide.
See below for updated list of upcoming events.
|DIA (the Drug Information Association), 2017
18 – 22 June, 2017 | Chicago, USA
Richmond Pharmacology’s Principal Investigators Dr Taubel and Dr Lorch will be presenting at DIA 2017,Chicago
Join our CEO Dr Jorg Taubel, who will be presenting on the topic ‘Combined Adaptive Early Phase Trials: From First-Time-in-Human to Proof of Concept in One Protocol’ Tuesday AM – 20th of June.
Dr Ulrike Lorch will also be in attendance presenting ‘Combined Adaptive Early Phase Trials: From First-Time-in-Human to Proof of Concept in One Protocol’ her presentation will also take place Tuesday AM –20th June.
For more information visit: DIA-2017
I am very pleased with the Project Management of both studies undertaken on behalf of (blank) and any future studies we have to outsource will automatically be contracted to you.
Many thanks for your time today, most impressed with the quality of the follow up to our enquiry.
Please know that it has been an absolute pleasure collaborating with you and that I am most appreciative of the key contributions RPL has made to this project thus far. I hope I have the opportunity to work with RPL again in the very near future.
Richmond Pharmacology is a frequent contributor and recognised thought leader for various scientific meetingsRead more ›
Richmond Pharmacology has been settling into life in its New London Bridge Research Unit.Read more ›
Richmond Pharmacology has been busy settling in their first patients at the new London Bridge site.Read more ›